| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.00069 | 1 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.00042 | 1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00039 | 1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.00037 | 1 |